Drug Resistant Tuberculosis

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study.

A study conducted in eight countries with a middle or high burden of tuberculosis found that at least 10% of household contacts can be classified as resistant to TB infection, including those with high exposure.

Among patients with rheumatic diseases, treatment with any biologic increases the risk for tuberculosis, both reactivation and new-onset, with an incidence rate among biologic users that is 10 times higher in South Africa than in European countries, according to data published in Annals of the Rheumatic Diseases.